Eventide Asset Management - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2022$32,813,000
-1.0%
1,790,144
-13.1%
0.70%
+35.3%
Q1 2022$33,142,000
+73.9%
2,061,044
+51.4%
0.52%
+113.6%
Q4 2021$19,055,000
-25.3%
1,361,0440.0%0.24%
-27.7%
Q3 2021$25,492,000
+73.7%
1,361,044
+93.3%
0.34%
+70.6%
Q2 2021$14,678,000
-67.9%
704,000
-56.5%
0.20%
-70.9%
Q1 2021$45,729,000
+32.1%
1,617,573
+52.6%
0.68%
+27.7%
Q4 2020$34,620,000
+182.5%
1,060,000
+165.0%
0.53%
+121.2%
Q3 2020$12,256,000400,0000.24%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders